It is scheduled to become final by December 2023. The revisions are intended to promote the use of more modern risk management principles and reduce regulatory burdens on medical device manufacturers and importers by harmonizing domestic and international requirements (we previously reported).
Source:
Office of Information and Regulatory Affairs: Rule
Write a comment on this news.